Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

June 2, 2019

Study Completion Date

June 2, 2020

Conditions
Second-degree Hemorrhoids
Interventions
DRUG

Polidocanol foam (Atossisclerol® 3%)

The procedure will be performed in the Sims position or lithotomy position. A modified Blonde-Blanchard technique will be adopted, with the tangential injection of polidocanol foam into the submucosa of the apex of each hemorrhoidal pile, without exceeding three piles, and using a self-lighting open-ended anoscope and a 20-G needle in order to reduce bleeding

Trial Locations (1)

88100

University of Catanzaro, Catanzaro

All Listed Sponsors
collaborator

SICCR - Gaetano Gallo

UNKNOWN

lead

Societa Italiana di Chirurgia ColoRettale

NETWORK

NCT03791775 - Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease | Biotech Hunter | Biotech Hunter